Perrigo Inks $195M Sale Of UK Generics Manufacturer
Perrigo said Friday it is selling its generic pharmaceuticals manufacturing unit to a U.K.-based private equity firm for £156 million (about $195 million), as the Irish over-the-counter pharmaceuticals company looks to...To view the full article, register now.
Already a subscriber? Click here to view full article